Literature DB >> 16773428

Ala45Thr variation in neuroD1 gene is associated with early-onset type 2 diabetes with or without diabetic pedigree in Chinese.

Limei Liu1, Weiping Jia, Taishan Zheng, Ming Li, Huijuan Lu, Kunsan Xiang.   

Abstract

OBJECTIVE: Based on onset-age stratified analysis may be useful to determine the association of NeuroD1-Ala45Thr variation with susceptibility to genetic heterogeneous type 2 diabetes mellitus (T2DM), we investigated the Ala45Thr variation in unrelated early-onset and late-onset T2DM with or without diabetic pedigree and unrelated non-diabetic control subjects in Chinese.
METHODS: 175 early-onset and 194 late-onset type 2 diabetic patients were further divided into two subgroups according to with or without diabetic pedigree respectively. This NeuroD1-Ala45Thr variation were screened by PCR-direct sequencing in above 369 type 2 diabetic patients and 87 unrelated non-diabetic control subjects. We then compared the distribution of the Ala45Thr variation among the groups, searching for the predictive trends.
RESULTS: Frequencies of the variant (AA + GA genotype) in early-onset T2DM are obviously elevated, especially among diabetic pedigree subjects when compared to non-diabetic controls (p= 0.003) and late-onset T2DM subjects (p = 0.014). However, no significant differences were observed between late-onset T2DM with or without diabetic pedigree and non-diabetic control subjects.
CONCLUSIONS: Our results suggest that 1) the NeuroD1-Ala45Thr variation may itself have an important role in susceptibility to or be in disequilibrium with early-onset T2DM in Chinese; 2) the Ala45Thr may affect the onset pattern of T2DM, i.e., early-onset but not late-onset T2DM in Chinese; and 3) onset-age stratified analysis may be useful to determine the association of NeuroD1-Ala45Thr variation with susceptibility to genetic heterogeneous T2DM in Chinese.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773428     DOI: 10.1007/s11010-006-9217-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  High prevalence of mitochondrial diabetes mellitus in Japanese patients with major risk factors.

Authors:  M Fukui; K Nakano; H Obayashi; Y Kitagawa; N Nakamura; H Mori; S Kajiyama; S Wada; M Fujii; K Yoshimori; T Kanaitsuka; H Shigeta; M Kondo
Journal:  Metabolism       Date:  1997-07       Impact factor: 8.694

Review 2.  Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest.

Authors:  P Z Zimmet
Journal:  Diabetes Care       Date:  1992-02       Impact factor: 19.112

3.  Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis.

Authors:  Fotini K Kavvoura; John P A Ioannidis
Journal:  Hum Genet       Date:  2004-12-11       Impact factor: 4.132

4.  Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice.

Authors:  F J Naya; H P Huang; Y Qiu; H Mutoh; F J DeMayo; A B Leiter; M J Tsai
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

5.  Lack of association of the Ala45Thr variant in the BETA2/NEUROD1 with type 1 diabetes in Japanese.

Authors:  T Awata; K Inoue; I Inoue; T Abe; H Takino; Y Kanazawa; S Katayama
Journal:  Diabetes Res Clin Pract       Date:  2000-07       Impact factor: 5.602

6.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

Authors:  E H Hani; D A Stoffers; J C Chèvre; E Durand; V Stanojevic; C Dina; J F Habener; P Froguel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.

Authors:  M T Malecki; U S Jhala; A Antonellis; L Fields; A Doria; T Orban; M Saad; J H Warram; M Montminy; A S Krolewski
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

8.  A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus.

Authors:  E H Hani; L Suaud; P Boutin; J C Chèvre; E Durand; A Philippi; F Demenais; N Vionnet; H Furuta; G Velho; G I Bell; B Laine; P Froguel
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

9.  Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4.

Authors:  Azuma Kanatsuka; Yoshiharu Tokuyama; Osamu Nozaki; Kana Matsui; Tohru Egashira
Journal:  Metabolism       Date:  2002-09       Impact factor: 8.694

10.  The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 2 diabetes mellitus in a Polish population.

Authors:  M T Malecki; K Cyganek; T Klupa; J Sieradzki
Journal:  Acta Diabetol       Date:  2003-06       Impact factor: 4.280

View more
  4 in total

1.  Evaluation of variant A45T in NEUROD1/BETA2 for its association with type 2 diabetes mellitus.

Authors:  Xueyao Han; Jianzhong Xiao; Qian Ren; Yong Tang; Wenying Yang; Linong Ji
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

Review 2.  Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.

Authors:  Yisheng Yang; Lawrence Chan
Journal:  Endocr Rev       Date:  2016-04-01       Impact factor: 19.871

3.  A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family.

Authors:  Limei Liu; Hiroto Furuta; Asako Minami; Taishan Zheng; Weiping Jia; Kishio Nanjo; Kunsan Xiang
Journal:  Mol Cell Biochem       Date:  2007-04-18       Impact factor: 3.396

Review 4.  Xenopus pancreas development.

Authors:  Esther J Pearl; Cassandra K Bilogan; Sandeep Mukhi; Donald D Brown; Marko E Horb
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.